Brazil’s national public health foundation in Rio de Janeiro, with co-located vaccine/biologics manufacturing, pharmaceutical development, high-biosafety labs, a clinical research hospital, and a tech transfer office. Integration with Brazil’s health system speeds translation.
Fundação Oswaldo Cruz (Fiocruz) is Brazil’s national public health research foundation and graduate education institution, headquartered in Rio de Janeiro with a network of campuses and units across the country. Its industry-facing infrastructure includes co-located GMP facilities for vaccines and other biologics alongside a pharmaceutical development and manufacturing unit, enabling scale-up, quality testing, and technology transfer. Reference laboratories, high-biosafety facilities, and a clinical research hospital support surveillance, trials, and regulatory-grade evaluation in collaboration with public and private partners. Fiocruz’s research is sustained by competitive federal funding in Brazil and support from international agencies and foundations.